City

Bethesda (1)

Tehran (1)

Condition

DME (2)

Diabetic Macular Edema (1)

Diabetic Retinopathy (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

National Eye Institute (NEI) (1)

Shahid Beheshti University of Medical Sciences (1)

Collaborator

Intervention

prescription artificial tear in group 2 (1)

prescription artificial tear in group1 (1)

prescription topical ketorolac in group 1 (1)

prescription topical ketorolac in group 2 (1)

triamcinolone acetonide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

dme

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

DME Trial in Tehran (prescription topical ketorolac in group 1, prescription artificial tear in group 2, prescription topical

Completed

DME

prescription topical ketorolac in group 1
+3 more

Tehran, Iran, Islamic Republic of

Ophthalmic Research Center

Feb 20, 2021

Diabetic Retinopathy, Diabetic Macular Edema, DME Trial run by the NEI (Triamcinolone Acetonide)

Completed

Diabetic Retinopathy
+2 more

Triamcinolone Acetonide

Bethesda, Maryland

National Eye Institute (NEI)

Jun 30, 2017